78 studies found for:    Open Studies | "Bone Diseases, Infectious"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Bone Diseases, Infectious"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Progression of Spinal Fusion in Ankylosing Spondylitis
Condition: Spondylitis, Ankylosing
Intervention:
2 Recruiting Employment and Arthritis: Making it Work
Conditions: Rheumatoid Arthritis;   Ankylosing Spondylitis;   Lupus Erythematosus, Systemic;   Psoriatic Arthritis;   Other Connective Tissue Diseases;   Spondylarthropathy
Intervention: Behavioral: Employment and Arthritis: Making it Work
3 Not yet recruiting A Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNF(Alpha) Refractory Participants With Active Radiographic Axial Spondyloarthritis
Condition: Axial Spondyloarthritis
Interventions: Drug: Placebo;   Drug: Ustekinumab 45 mg;   Drug: Ustekinumab 90 mg;   Drug: Golimumab 50 mg
4 Unknown  Open Label Clinical Trial With Rituximab (MabThera ®) in Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Drug: rituximab
5 Not yet recruiting 16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Ankylosing Spondylitis
Condition: Spondylitis, Ankylosing
Interventions: Biological: Secukinumab;   Biological: Placebo
6 Recruiting Biologic Rheumatology Registry Across Canada
Conditions: Arthritis, Rheumatoid;   Spondylitis, Ankylosing;   Arthritis, Psoriatic
Intervention:
7 Not yet recruiting Study of Efficacy and Safety of Brodalumab Compared With Placebo in Subjects With Axial Spondyloarthritis
Condition: Axial Spondyloarthritis
Interventions: Drug: Brodalumab 210 mg;   Drug: Placebo
8 Not yet recruiting An Efficacy and Safety Study of Ustekinumab in Participants With Active Nonradiographic Axial Spondyloarthritis
Condition: Nonradiographic Axial Spondylitis, Ankylosing
Interventions: Drug: Group 1: Placebo;   Drug: Group 2: Ustekinumab 45 mg;   Drug: Group 3: Ustekinumab 90 mg
9 Recruiting Registry of Korean Patients With Rheumatic Disease Using Biologics
Conditions: Rheumatoid Arthritis;   Ankylosing Spondylitis;   Psoriatic Arthritis
Intervention:
10 Unknown  Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Ankylosing Spondylitis (AS)
Condition: Ankylosing Spondylitis
Intervention: Biological: Human umbilical cord-derived MSCs
11 Unknown  The RATIO: Registry of Infections and Lymphoma in Patients Treated With TNF-a Antagonists
Conditions: Rheumatoid Arthritis;   Crohn's Disease;   Ankylosing Spondylitis;   Psoriasis
Intervention: Drug: TNF-alpha antagonists
12 Not yet recruiting A Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNF(Alpha) Naive Participants With Active Radiographic Axial Spondyloarthritis
Condition: Axial Spondyloarthritis
Interventions: Drug: Placebo;   Drug: Ustekinumab 45 mg;   Drug: Ustekinumab 90 mg;   Drug: Golimumab 50 mg
13 Unknown  Assessment of SpondyloArthritis Society (ASAS) Classification and Diagnostic Criteria for Early Axial Spondyloarthritis (SpA)
Conditions: Spondyloarthritis;   Spondylarthropathy;   Spondylitis, Ankylosing
Intervention:
14 Recruiting Treatment of Axial Spondyloarthritis With Reduced Doses of NSAIDs
Condition: Axial Spondyloarthritis
Interventions: Drug: Ibuprofen;   Drug: Placebo
15 Recruiting 16-week Efficacy and 3-year Safety, Tolerability and Efficacy of Secukinumab in Active Ankylosing Spondylitis Patients
Condition: Spondylitis, Ankylosing
Interventions: Drug: Secukinumab;   Drug: Placebo secukinumab
16 Recruiting Efficacy of Oral Antibiotic Therapy Compared to Intravenous Antibiotic Therapy for the Treatment of Diabetic Foot Osteomyelitis
Condition: Osteomyelitis
Interventions: Drug: piperacillin/tazobactam, cefepime, metronidazole, aztreonam,vancomycin, daptomycin, linezolid ,meropenem;   Drug: sulfamethoxazole/trimethoprim , clindamycin ,linezolid, moxifloxacin ,ciprofloxacin ,metronidazole
17 Recruiting Regulatory B Cells in Inflammatory Rheumatisms and Biomarkers of Response to Biologic Treatments
Conditions: Rheumatoid Arthritis;   Osteoarthritis;   Systemic Lupus Erythematosus;   Sjogren's Syndrome;   Scleroderma;   Spondylitis;   Gout;   Spinal Disease;   Chondrocalcinosis
Intervention:
18 Recruiting Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases
Conditions: Rheumatoid Arthritis;   Ankylosing Spondylitis;   Systemic Lupus Erythematosus;   Psoriasis;   Behcet's Disease;   Wegener's Granulomatosis;   Takayasu's Disease;   Crohn's Disease;   Ulcerative Colitis;   Autoimmune Hepatitis;   Sclerosing Cholangitis
Intervention: Drug: Interleukin 2
19 Unknown  Pilot Open Label Clinical Trial With Abatacept in Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Drug: abatacept
20 Unknown  Presence of IBD Specific Antibodies (ASCA, ALCA, ACCA, AMCA) in the Sera of Patients With Spondyloarthropathy
Conditions: Psoriatic Arthritis;   Ankylosing Spondylitis;   Undifferentiated Spondyloarthropathy
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years